相关实验视频

Updated: Jun 14, 2025

Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
05:54

Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials

Published on: May 10, 2024

1.4K

关于与神经退行性疾病相关的传统中医学的新兴见解:图书统计分析

Yijie Luo1, Boqi Hu2, Zhenjun Yuan3

  • 1West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, 610041, China; West China School of Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.

Journal of ethnopharmacology
|September 6, 2024
PubMed
概括

传统中医 (TCM) 对神经退行性疾病的治疗越来越有希望,网络药理学作为关键研究范式. 自和微生物群是TCM的新兴焦点.

关键词:
阿尔茨海默氏症的疾病(5)粉样蛋白β (aβ) (PubChem CID: 57339250) 的使用情况无库 (AUC) (PubChem CID: 91458) 已经成为一个常见问题.巴伊卡林 (PubChem CID: 64982) 是一个比洛巴利德 (PubChem CID: 73581) 的使用情况卡斯特罗丁 (PubChem CID: 115067) 是一种药物.银科利德 (PubChem CID: 11973122) 的使用情况人参化物Rg1 (PubChem CID: 441923) 是一种银素 (PubChem CID: 44559009) 的使用情况网络药理学 ((4))神经退行性疾病(2) 是一种神经退行性疾病.传统的中国医药 ((1))自 (自) (6) 自文献计数学 (bibliometrics) (3) 这是一个很好的方法.

更多相关视频

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

476
Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells10:33

Exploring the Two Herb Combination Strategy to Treat Injured PC12 Cells

Published on: November 18, 2022

1.3K

相关概念视频

Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
499